thiophenes has been researched along with Hip Fractures in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V | 1 |
| Reid, IR | 1 |
| Bakchoul, T; Ganzel, C; Greinacher, A; Rowe, JM; Tvito, A | 1 |
| Balogh, A; Boonen, S; Brandi, ML; Brixen, K; Cormier, C; Delmas, PD; Diez-Perez, A; Felsenberg, D; Goemaere, S; Meunier, PJ; Reginster, JY; Rizzoli, R; Spector, TD | 1 |
| Garcia Nuño, L; Granero Xiberta, J; Soler Minoves, JM | 1 |
| Aquino, JP; Benhamou, CL; Boonen, S; Borgström, F; Kaufman, JM; Reginster, JY; Seeman, E; Semler, J; Vellas, B | 1 |
| Charle-Crespo, MÁ; Gomes-Carvalho, CS; Guerra-García, MM; Prejigueiro-Santás, A; Puga-Sarmiento, E; Rodríguez-Fernández, JB | 1 |
| Mosekilde, L; Rejnmark, L; Schwartz, F; Vestergaard, P | 1 |
| Davis, M; Fisher, A; Martin, J; Srikusalanukul, W | 1 |
| Cerbone, AM; Coppola, A; Franchini, M; Ruosi, C; Tufano, A | 1 |
| Adami, S; Buda, S; Cagnoni, C; Degli Esposti, L; Magliaro, C; Minisola, S; Rossini, M; Sinigaglia, L; Veronesi, C | 1 |
| Davey, DA | 1 |
| Briongos, L; Dueñas-Laita, A; García-Alonso, M; Pérez-Castrillón, JL; Ruiz-Mambrilla, M; Sañudo, S | 1 |
| Halkin, V; Lecart, MP; Reginster, JY; Sarlet, N | 1 |
| Adami, S | 1 |
| Kendler, DL | 1 |
| Close, P; Neuprez, A; Reginster, JY | 1 |
| Krieg, MA; Lamy, O | 1 |
| Badurski, J; Bruyère, O; Cannata, J; de Vernejoul, MC; Detilleux, J; Isaia, G; Ortolani, S; Reginster, JY; Roux, C; Slosman, D | 1 |
| Blake, GM; Fogelman, I | 1 |
5 review(s) available for thiophenes and Hip Fractures
| Article | Year |
|---|---|
Preventing postsurgical venous thromboembolism: pharmacological approaches.
Topics: Aged; Anticoagulants; Antithrombins; Arthroscopy; Bariatric Surgery; Benzimidazoles; Blood Coagulation Disorders, Inherited; Dabigatran; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Kidney; Knee; Laparoscopy; Morpholines; Neoplasms; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism | 2011 |
[Prevention of hip fractures in the elderly: where are we in 2003?].
Topics: Aged; Calcitonin; Calcium; Dietary Supplements; Diphosphonates; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D | 2003 |
Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action.
Topics: Animals; Bone and Bones; Female; Hip Fractures; Humans; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Fractures; Thiophenes; Treatment Outcome | 2006 |
Developments in the pharmacotherapeutic management of osteoporosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Carrier Proteins; Cathepsin K; Cathepsins; Denosumab; Diphosphonates; Drug Administration Schedule; Female; Hip Fractures; Humans; Membrane Glycoproteins; Meta-Analysis as Topic; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Protease Inhibitors; Randomized Controlled Trials as Topic; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Selective Estrogen Receptor Modulators; Spinal Fractures; Teriparatide; Thiophenes | 2006 |
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy.
Topics: Bone Density; Female; Hip Fractures; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Spine; Thiophenes; Treatment Outcome | 2006 |
3 trial(s) available for thiophenes and Hip Fractures
| Article | Year |
|---|---|
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Double-Blind Method; Female; Fractures, Bone; Hip Fractures; Humans; Longitudinal Studies; Organometallic Compounds; Osteoporosis, Postmenopausal; Spinal Injuries; Thiophenes; Treatment Outcome | 2008 |
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Topics: Aged, 80 and over; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Female; Hip Fractures; Humans; Intention to Treat Analysis; Organometallic Compounds; Osteoporosis, Postmenopausal; Quality of Life; Spinal Fractures; Thiophenes; Treatment Outcome | 2010 |
Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Topics: Aged; Bone Density Conservation Agents; Bone Resorption; Female; Hip Fractures; Humans; Organometallic Compounds; Osteogenesis; Osteoporosis, Postmenopausal; Risk Factors; Spinal Fractures; Thiophenes | 2006 |
13 other study(ies) available for thiophenes and Hip Fractures
| Article | Year |
|---|---|
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid | 2014 |
Efficacy, effectiveness and side effects of medications used to prevent fractures.
Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid | 2015 |
Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Blood Platelets; Dalteparin; Female; Fondaparinux; Hip Fractures; Hirudins; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Morpholines; Peptide Fragments; Platelet Count; Polysaccharides; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis | 2015 |
[Thromboembolic disease in orthopedic surgery].
Topics: Anesthesia, Conduction; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Early Ambulation; Enoxaparin; Fibrinolytic Agents; Hip Fractures; Humans; Intraoperative Care; Morpholines; Orthopedics; Postoperative Care; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Thiophenes; Time Factors; Venous Thromboembolism | 2008 |
[Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].
Topics: Aged; Alendronate; Bone Density Conservation Agents; Drug Prescriptions; Etidronic Acid; Female; Hip Fractures; Humans; Incidence; Male; Middle Aged; Organometallic Compounds; Osteoporotic Fractures; Retrospective Studies; Risedronic Acid; Spain; Thiophenes | 2011 |
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Denmark; Diphosphonates; Female; Femoral Fractures; Hip Fractures; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Risk Factors; Thiophenes | 2011 |
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
Topics: Aged; Aged, 80 and over; Australian Capital Territory; Bone Density Conservation Agents; Diphosphonates; Drug Prescriptions; Female; Hip Fractures; Humans; Incidence; Jaw Diseases; Male; Middle Aged; Organometallic Compounds; Osteonecrosis; Osteoporosis; Prevalence; Thiophenes | 2010 |
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Comorbidity; Databases, Factual; Diagnostic Techniques and Procedures; Diphosphonates; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Health Services; Health Services Administration; Hip Fractures; Humans; Medical Record Linkage; Osteoporosis, Postmenopausal; Polypharmacy; Practice Guidelines as Topic; Prescriptions; Recurrence; Retrospective Studies; Risk; Risk Factors; Thiophenes; Vitamin D | 2012 |
Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons.
Topics: Adult; Age Factors; Aged; Algorithms; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Etidronic Acid; Female; Fractures, Bone; Hip Fractures; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Risedronic Acid; Spinal Fractures; Thiophenes | 2012 |
Treatment of osteoporosis and hip fractures in a Spanish health area.
Topics: Bone Density Conservation Agents; Diphosphonates; Hip Fractures; Humans; Longitudinal Studies; Organometallic Compounds; Osteoporosis; Raloxifene Hydrochloride; Retrospective Studies; Spain; Thiophenes | 2013 |
[New medication combines osteo-anabolic and anti-resorptive effects. Double strategy against osteoporosis].
Topics: Animals; Bone Density; Bone Resorption; Controlled Clinical Trials as Topic; Double-Blind Method; Female; Hip Fractures; Humans; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Placebos; Rats; Spinal Fractures; Thiophenes; Time Factors | 2004 |
[The necessity of cost-effectiveness analysis in osteoporosis].
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Decision Making; Diphosphonates; Female; Fractures, Bone; Health Care Costs; Hip Fractures; Hormone Replacement Therapy; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Organometallic Compounds; Osteoporosis; Parathyroid Hormone; Quality of Life; Selective Estrogen Receptor Modulators; Thiophenes; Vitamin D | 2007 |
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate.
Topics: Aged; Aged, 80 and over; Bone Density; Female; Femur Neck; Hip Fractures; Humans; Incidence; Organometallic Compounds; Osteoporosis, Postmenopausal; Radiography; Thiophenes | 2007 |